Medical Grand Rounds

Leonard Calabrese, DO
Head, Section of Clinical Immunology, Department of Rheumatic and Immunologic Disease, and Department of Infectious Diseases, The Cleveland Clinic Foundation; and Professor of Medicine, The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Leonard Calabrese, DO, Department of Rheumatologic and Immunologic Disease, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he has served as a consultant to the Abbott and Amgen corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Leonard Calabrese, DO
Head, Section of Clinical Immunology, Department of Rheumatic and Immunologic Disease, and Department of Infectious Diseases, The Cleveland Clinic Foundation; and Professor of Medicine, The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Leonard Calabrese, DO, Department of Rheumatologic and Immunologic Disease, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he has served as a consultant to the Abbott and Amgen corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Leonard Calabrese, DO
Head, Section of Clinical Immunology, Department of Rheumatic and Immunologic Disease, and Department of Infectious Diseases, The Cleveland Clinic Foundation; and Professor of Medicine, The Cleveland Clinic Lerner College of Medicine of Case Western Reserve University

Address: Leonard Calabrese, DO, Department of Rheumatologic and Immunologic Disease, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he has served as a consultant to the Abbott and Amgen corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Gerald B. Appel, MD
Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Address: Gerald B. Appel, MD, Presbyterian Hospital, 622 West 168th Street, Room 4124, New York, NY 10032

The author indicates that he has been a speaker and a consultant for and has received research support from the Merck, Pfizer, AstraZeneca, Bristol-Myers Squib, Aspreva, Novartis, Roche, and Genentech corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Gerald B. Appel, MD
Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Address: Gerald B. Appel, MD, Presbyterian Hospital, 622 West 168th Street, Room 4124, New York, NY 10032

The author indicates that he has been a speaker and a consultant for and has received research support from the Merck, Pfizer, AstraZeneca, Bristol-Myers Squib, Aspreva, Novartis, Roche, and Genentech corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Gerald B. Appel, MD
Director of Clinical Nephrology and Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, NY

Address: Gerald B. Appel, MD, Presbyterian Hospital, 622 West 168th Street, Room 4124, New York, NY 10032

The author indicates that he has been a speaker and a consultant for and has received research support from the Merck, Pfizer, AstraZeneca, Bristol-Myers Squib, Aspreva, Novartis, Roche, and Genentech corporations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

James L. Januzzi, Jr, MD
Assistant Professor of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston

Address: James L. Januzzi, Jr, MD, Massachusetts General Hospital, Cardiac Unit Associates, 55 Fruit Street, YAN 5, Boston, MA 02114

The author has indicated that he has served as a consultant and a speaker for the Ortho and Roche corportations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

James L. Januzzi, Jr, MD
Assistant Professor of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston

Address: James L. Januzzi, Jr, MD, Massachusetts General Hospital, Cardiac Unit Associates, 55 Fruit Street, YAN 5, Boston, MA 02114

The author has indicated that he has served as a consultant and a speaker for the Ortho and Roche corportations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

James L. Januzzi, Jr, MD
Assistant Professor of Medicine, Harvard Medical School, Massachusetts General Hospital, Boston

Address: James L. Januzzi, Jr, MD, Massachusetts General Hospital, Cardiac Unit Associates, 55 Fruit Street, YAN 5, Boston, MA 02114

The author has indicated that he has served as a consultant and a speaker for the Ortho and Roche corportations.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Michael A. Levine, MD
Chairman, Division of Pediatrics, The Cleveland Clinic Foundation

Address: Michael A. Levine, MD, Department of Pediatric Endocrinology, S25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Michael A. Levine, MD
Chairman, Division of Pediatrics, The Cleveland Clinic Foundation

Address: Michael A. Levine, MD, Department of Pediatric Endocrinology, S25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Michael A. Levine, MD
Chairman, Division of Pediatrics, The Cleveland Clinic Foundation

Address: Michael A. Levine, MD, Department of Pediatric Endocrinology, S25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Heart Center Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Neha Parekh, MS, RD, LD, CNSD
Intestinal Rehabilitation Program, Departments of Gastroenterology and General Surgery, The Cleveland Clinic Foundation

Douglas Seidner, MD
Department of Gastroenterology, The Cleveland Clinic Foundation

Ezra Steiger, MD
Department of General Surgery, The Cleveland Clinic Foundation

Address: Douglas Seidner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Neha Parekh, MS, RD, LD, CNSD
Intestinal Rehabilitation Program, Departments of Gastroenterology and General Surgery, The Cleveland Clinic Foundation

Douglas Seidner, MD
Department of Gastroenterology, The Cleveland Clinic Foundation

Ezra Steiger, MD
Department of General Surgery, The Cleveland Clinic Foundation

Address: Douglas Seidner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Neha Parekh, MS, RD, LD, CNSD
Intestinal Rehabilitation Program, Departments of Gastroenterology and General Surgery, The Cleveland Clinic Foundation

Douglas Seidner, MD
Department of Gastroenterology, The Cleveland Clinic Foundation

Ezra Steiger, MD
Department of General Surgery, The Cleveland Clinic Foundation

Address: Douglas Seidner, MD, Department of Gastroenterology, A30, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: Carol Langford, MD, MHS, Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

No therapeutic agents are specifically approved for the treatment of Wegener granulomatosis. All references to a commercial product constitute an unlabeled use.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: Carol Langford, MD, MHS, Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

No therapeutic agents are specifically approved for the treatment of Wegener granulomatosis. All references to a commercial product constitute an unlabeled use.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Carol A. Langford, MD, MHS
Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, The Cleveland Clinic Foundation

Address: Carol Langford, MD, MHS, Director, Center for Vasculitis Care and Research, Department of Rheumatic and Immunologic Diseases, A50, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

No therapeutic agents are specifically approved for the treatment of Wegener granulomatosis. All references to a commercial product constitute an unlabeled use.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

George E. Tesar, MD
Department of Psychiatry and Psychology, The Cleveland Clinic Foundation

Address: George E. Tesar, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

George E. Tesar, MD
Department of Psychiatry and Psychology, The Cleveland Clinic Foundation

Address: George E. Tesar, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

George E. Tesar, MD
Department of Psychiatry and Psychology, The Cleveland Clinic Foundation

Address: George E. Tesar, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Amir Hamrahian, MD
Department of Endocrinology, Diabetes, and Metabolism, The Cleveland Clinic Foundation

Address: Amir H. Hamrahian, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Amir Hamrahian, MD
Department of Endocrinology, Diabetes, and Metabolism, The Cleveland Clinic Foundation

Address: Amir H. Hamrahian, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Amir Hamrahian, MD
Department of Endocrinology, Diabetes, and Metabolism, The Cleveland Clinic Foundation

Address: Amir H. Hamrahian, MD, Department of Endocrinology, Diabetes, and Metabolism, A53, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.